CN111514203A - Application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis - Google Patents

Application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis Download PDF

Info

Publication number
CN111514203A
CN111514203A CN202010570186.XA CN202010570186A CN111514203A CN 111514203 A CN111514203 A CN 111514203A CN 202010570186 A CN202010570186 A CN 202010570186A CN 111514203 A CN111514203 A CN 111514203A
Authority
CN
China
Prior art keywords
tinea
charcoal
gallic acid
cruris
pedis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010570186.XA
Other languages
Chinese (zh)
Inventor
顾琦
梁莹
陈军
顾薇
苏曼
王昊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Chinese Medicine
Original Assignee
Nanjing University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Chinese Medicine filed Critical Nanjing University of Chinese Medicine
Priority to CN202010570186.XA priority Critical patent/CN111514203A/en
Publication of CN111514203A publication Critical patent/CN111514203A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/11Aldehydes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis, and application of garden burnet charcoal in preparation of medicines or daily necessities. Simultaneously provides the application of one or more components of gallic acid, pyrogallic acid, gallic acid methyl ester, gallic acid ethyl ester and protocatechuic aldehyde in preventing and treating tinea corporis and cruris, tinea manus and pedis, and the application in the preparation of medicines or daily necessities. The present invention shows that the sanguisorba root charcoal can obviously inhibit the growth of tinea corporis, tinea cruris, tinea manus and tinea pedis, and the effect of the sanguisorba root charcoal is equivalent to that of common traditional Chinese medicines of radix sophorae flavescentis and golden larch bark for treating tinea. After the sanguisorba officinalis charcoal is administrated, the growth of trichophyton rubrum is obviously inhibited by ocular observation. Clinical curative effect observation shows that the cure rate of patients after 4 weeks of treatment by 0.5 percent sanguisorba officinalis charcoal gel reaches 96.15 percent, and half of patients are cured. Meanwhile, the main components of the garden burnet, namely gallic acid, pyrogallic acid, gallic acid methyl ester, gallic acid ethyl ester and protocatechuic aldehyde, have remarkable anti-trichophyton rubrum effects, and the contents are not reported.

Description

Application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis
Technical Field
The invention belongs to the field of external application of traditional Chinese medicines, and particularly relates to application of carbonized sanguisorba root in prevention and treatment of tinea corporis, tinea cruris, tinea manus and tinea pedis.
Background
The pathogenic fungi of tinea corporis, cruris, tinea manuum and tinea pedis are dermatophytes which are both characterized by being cutiphilic. About more than 40 kinds of dermatophytes are available, and about more than 20 kinds of dermatophytes can cause diseases in human beings or animals. The domestic circulation and regulation data of various regions and different hospitals show that pathogenic bacteria of tinea corporis, tinea cruris, tinea manus and pedis are approximately the same, the most common is trichophyton rubrum which is the main pathogenic bacteria, and the other pathogenic bacteria comprise trichophyton mentagrophytes, microsporum canis, microsporum gypseum and the like. Dermatophytes can be transmitted from person to person, animal to person, pollutant to person, and various parts of the human body. The physique and environmental factors of patients play a certain role in the pathogenesis, such as the damp-heat area and the high-temperature season are the causes of tinea corporis, tinea cruris, tinea manuum and tinea pedis, the patients wear airtight and over-tight clothes, and the obese and hyperhidrosis patients or drivers are prone to suffer from femoral diseases; the feed is used for raising pets, diabetics, close contact infected persons and pollutants, and patients suffering from tinea manus, tinea pedis or onychomycosis are infected by other fungal infections at other parts and are susceptible to tinea corporis.
The clinical treatment of tinea corporis, cruris, tinea manus and pedis generally adopts local external administration, however, patients who apply glucocorticoid and immunosuppressant locally or systemically for a long time can make skin lesions atypical and form 'indiscernible tinea'. ("Chinese guide for diagnosis and treatment of tinea corporis and tinea cruris" 2018 revised edition)
The radix Sangusorbae is dried root of Sanguisorbae officinalis L. or Sanguisorbae officinalis L. var. longifolia (Bert.) Kuet Li, which is commonly called "sanguisorbae officinalis". The charred radix Sangusorbae is processed by charring method, and has brown surface, brown interior, charred fragrance, and bitter taste. Sanguisorba root, charred and slightly cold in nature, bitter, sour and astringent in flavor, enters liver and large intestine meridians. Has effects in cooling blood, stopping bleeding, removing toxic substance, and healing sore, and can be used for treating hematochezia, hemorrhoidal bleeding, bloody dysentery, metrorrhagia, scald due to hot water and fire, carbuncle, swelling, and sore. The current drug effect reports of the sanguisorba officinalis charcoal are mainly for hemostasis and burn and scald treatment (in the 'Chinese pharmacopoeia' 2015 edition), the report on the antibacterial effect is few, the report on the tinea corporis and cruris pathogenic bacteria such as trichophyton rubrum and the like is not found, the report on the prevention or treatment of the tinea corporis and cruris is not found, and the description of the type is not found in ancient books.
Disclosure of Invention
The invention provides application of garden burnet root charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis.
Simultaneously provides the application of the garden burnet root charcoal in preparing the medicaments or daily necessities for preventing and treating tinea corporis, tinea cruris, tinea manus and pedis.
The radix Sangusorbae charcoal is radix Sangusorbae charcoal powder or extract.
As a further improvement, the extraction solvent of the garden burnet root charcoal extract is an ethanol water solution.
As a further improvement, the extraction solvent of the garden burnet root charcoal extract is 75% ethanol extract. The invention also provides application of one or more components of gallic acid, pyrogallic acid, gallic acid methyl ester, gallic acid ethyl ester and protocatechuic aldehyde in preventing and treating tinea corporis, tinea cruris and tinea manus and pedis.
And one or more components of gallic acid, pyrogallic acid, gallic acid methyl ester, gallic acid ethyl ester and protocatechuic aldehyde in the preparation of medicines or daily necessities for preventing and treating tinea corporis, tinea cruris, tinea manus and pedis.
Advantageous effects
The invention shows that the sanguisorba officinalis charcoal extract can obviously inhibit the growth of trichophyton rubrum (ATCC MYA-4438), the minimum inhibitory concentration MIC of the sanguisorba officinalis charcoal extract reaches 64 mu g/ml, the effect of the sanguisorba officinalis charcoal extract is equivalent to that of common traditional Chinese medicines of radix sophorae flavescentis and golden larch bark for tinea corporis and tinea cruris and tinea manus and pedis, the sanguisorba officinalis charcoal extract is superior to that of crude medicinal materials of rheum officinale, clove, common cnidium fruit, radix stemonae, scutellaria baicalensis, fructus kochiae, male. The flora shape of the sanguisorba officinalis after administration is observed by 10 times of an ocular lens and 40 times of an objective lens, hypha separation becomes fuzzy after administration of sanguisorba officinalis charcoal (0.5 × MIC), the medicine influences the growth of hypha, and the hypha is hardly separated after administration of sanguisorba officinalis charcoal (1 × MIC), so that the growth is obviously inhibited. Then the sanguisorba officinalis charcoal gel with the content of 0.5 percent is administrated to patients for clinical observation, and the clinical curative effect shows that the cure rate of the patients reaches 96.15 percent after the sanguisorba officinalis charcoal gel is used for treating for 4 weeks, wherein half of the patients are cured.
Drawings
The invention will be further explained with reference to the drawings, in which:
FIG. 1 is a figure of charred sanguisorba officinalis prepared by processing sanguisorba officinalis
FIG. 2 shows total ion flow, A-anion mode and B-cation mode of radix Sangusorbae charcoal extract
FIG. 3 the relative content distribution of the components in the extract of Garden Burnet root charcoal
FIG. 4 microscopic observation results of administration of carbonized sanguisorba root to Trichophyton rubrum, wherein A: normal growth control wells; b: after administration of sanguisorba officinalis charcoal (0.5 × MIC); c: after administration of Garden Burnet root charcoal (1 × MIC)
Detailed Description
The technical solution of the present invention is further described below with reference to specific examples, which are not intended to limit the technical solution.
Example 1 examination of the Activity of Garden Burnet root charcoal against Trichophyton rubrum
The method comprises measuring the inhibitory effect of Garden Burnet root charcoal on Trichophyton rubrum by micro liquid-based dilution method, comparing with various common antibacterial traditional Chinese medicines such as fructus Cnidii, Kochiae fructus, spina Gleditsiae, cortex pseudolaricis, cortex Dictamni Radicis, and radix Sophorae Flavescentis, and comparing with garden burnet root which is the original medicinal material of garden burnet root charcoal, wherein the shape change before and after processing is shown in figure 1.
1. Bacterial strains
Trichophyton rubrum ATCC MYA-4438 was purchased from American Type Culture Collection (ATCC).
2. Preparation of samples to be tested
Respectively taking 10g of medicinal powder of fructus cnidii, fructus kochiae, spina gleditsiae, cortex pseudolaricis, cortex dictamni, radix sophorae flavescentis, radix sanguisorbae and carbonized sanguisorba root, adding 10 times of ethanol aqueous solution, soaking at 50 ℃ overnight, carrying out ultrasonic treatment at 50 ℃ for 1h, filtering, carrying out rotary evaporation drying at 50 ℃ until no liquid flows, and drying in an oven at the same temperature for 48h to obtain a sample to be detected.
Wherein the ethanol aqueous solution is preferably 75% ethanol solution.
3. Activation of bacterial strains
The frozen trichophyton rubrum glycerin tube is streaked and inoculated to a PDA plate, and the PDA plate is cultured for 6 days under the conditions of 35 ℃ and 80% of humidity.
4. Inoculation preparation
The plate was covered with 5ml of 0.9% NaCl solution, and the surface of the plate was gently scraped with an applicator to obtain a spore suspension. After diluting the suspension 100-fold, counting was performed using a microscope and a red blood cell counter. The counting results were as follows: 47, 57, 44, 54. The concentration of the stostespores is about 505,000 spores/ml. Mu.l of this culture was added to 250ml of a test medium (RPMI 1640 supplemented with 0.165M MOPS, pH 7.0) to obtain an inoculum.
5. Compound assay plate preparation
On the day of experiment, a sample to be detected is firstly dissolved in DMSO and then prepared into a mother solution of 51.2 mg/ml; the control Fluconazole was dissolved in DMSO and then prepared into 12.8mg/ml mother liquor, wherein the DMSO concentration was controlled at 0.05%.
1) Preparation of compound master
Compounds were diluted 11 times in 2-fold gradients in 96-V well plates to give 100-fold working solution: 51.2, 25.6, 12.8, 6.4, 3.2, 1.6, 0.8, 0.4, 0.2, 0.1, 0.05, 0 mg/ml.
Fluconazole performed 11 2-fold gradient dilutions in 96-V well plates to give 100-fold working solution: 6.4, 3.2, 1.6, 0.8, 0.4, 0.2, 0.1, 0.05, 0.025, 0.0125, 0.00625, 0 mg/ml.
2) Compound daughter board preparation
Transfer 2. mu.l of compound working solution from the compound master plate to a 96-U well plate to which a medium was added to obtain a compound detection plate. Three in parallel.
6. Compound assay plate inoculation
198. mu.l of each fungal inoculum was added to the compound assay plate to obtain the MIC assay plate.
MIC detection
And (3) placing the MIC detection plate under the conditions of 35 ℃ and 80% humidity, and reading the MIC value after standing and culturing for 4 days. MIC (minimal Inhibitory concentration) is the minimum Inhibitory concentration, and refers to the minimum drug concentration that can inhibit the growth of pathogenic bacteria in a culture medium after 18 to 24 hours of in vitro bacteria culture, and MIC is an index for measuring the antibacterial activity of antibacterial drugs. MIC read criteria are referenced in table 1 and results are shown in table 2.
TABLE 1 MIC judgement of antibiotics for test fungi (cf. CLSI M38)
Figure BDA0002549312910000041
The reference MIC value for CLSI to Trichophyton rubrum ATCC MYA-4438 was 0.5-4. mu.g/ml (4 days of culture).
TABLE 2 determination of Minimal Inhibitory Concentration (MIC) of extracts of herbs on Trichophyton rubrum
Figure BDA0002549312910000051
The results show that the sanguisorba charcoal has obvious inhibiting effect on trichophyton rubrum, and has the effect equivalent to that of common traditional Chinese medicines of radix sophorae flavescentis and golden larch bark for preventing and treating tinea corporis, tinea cruris and tinea manus and pedis, and the radix sophorae flavescentis and the golden larch bark are developed into traditional Chinese medicine preparations for preventing and treating tinea corporis, tinea cruris and tinea manus and pedis as monarch medicines. The bacteriostatic effect of the garden burnet root charcoal is superior to that of other clinically common bacteriostatic traditional Chinese medicines of common cnidium fruit, broom cypress fruit, spina gleditsiae and cortex dictamni, and is also superior to that of the medicinal material garden burnet root before processing, and the bacteriostatic effect of the garden burnet root charcoal is not reported.
Example 2 analysis of the composition of Garden Burnet root charcoal extract
In example 1, the garden burnet root charcoal extract was prepared under item "2" and subjected to compositional analysis by hplc-ms under the following analysis conditions:
chromatographic conditions are as follows: gradient elution was performed using an Agilent Poroshell 120EC-C18(2.1 mm. times.50 mm,2.7 μm) column at 30 ℃ and acetonitrile as mobile phase A and water (containing 0.1% formic acid) as mobile phase B as in Table 3 at a flow rate of 0.30mL/min and a sample size of 1 μ L.
TABLE 3 procedure for mobile phase gradient elution
Figure BDA0002549312910000052
Primary mass spectrum conditions: an electrospray ionization (ESI) positive and negative ion mode is adopted, the temperature of dry gas is 300 ℃, the pressure of atomizing gas is 241.3kPa, the outlet voltage of a capillary tube is 100V, the flow rate of dry gas is 3L/min, the voltage of the capillary tube is 3.5k V, and the mass scanning range m/z is 100-600.
Secondary mass spectrum conditions: the method adopts a multi-reaction monitoring (MRM) mode, the capillary voltage is 5500V (positive ion mode), -4500V (negative ion mode), the desolventizing temperature is 550 ℃, the air curtain pressure is 241.3kPa, the pressure of an atomizer and a drying gas is 379.2kPa, the purity of nitrogen used by an ion source is more than or equal to 95%, and the purity of a collision gas is more than or equal to 99.999.
The experimental results are as follows: the total ion flow diagram under positive and negative ions of the garden burnet root charcoal extract is shown in figure 2. 140 chemical component databases are established by collecting relevant documents at home and abroad and databases at home and abroad. According to the high-resolution relative molecular mass of the compound, secondary mass spectrum fragment information and references, HPLC-Q/TOF-MS result analysis shows that 54 components are obtained by identifying the garden burnet root charcoal, 20 gallic acid compounds, 9 ellagic acid compounds, 7 catechin compounds, 10 triterpenoid saponins and aglycon compounds thereof and 8 other compounds, the relative content distribution of which is shown in figure 3, and it can be seen that 4 main components in the garden burnet root charcoal are respectively gallic acid, ellagic acid compounds, catechin compounds, triterpenoid saponins and aglycon compounds thereof; the content of gallic acid is highest, and the identified contents include gallic acid, methyl gallate, methoxy methyl gallate-5-O-sulfate, galloyl-methyl glucoside, and ethyl gallate. Ellagic acid and gallic acid are both hydrolyzed tannin, and relatively high content of ellagic acid, 3,4' -O-dimethyl ellagic acid, and galloylellagic acid.
Example 4 mechanism study of Garden Burnet root charcoal against Trichophyton rubrum
1. Research on substance basis of sanguisorba charcoal for resisting trichophyton rubrum
The anti-trichophyton rubrum effect of the garden burnet root charcoal active ingredients gallic acid, pyrogallic acid, methyl gallate, ethyl gallate, catechin, ellagic acid, ursolic acid and protocatechuic aldehyde was determined by a trace liquid-based dilution method, the sample preparation and the determination method were the same as example 1, and the experimental results are shown in table 4.
TABLE 4 minimum inhibitory concentration of sanguisorba officinalis active ingredient against Trichophyton rubrum
Figure BDA0002549312910000061
Figure BDA0002549312910000071
The results show that the main substance basis of the sanguisorba officinalis charcoal for resisting trichophyton rubrum can be gallic acid, pyrogallic acid, methyl gallate, ethyl gallate and protocatechuic aldehyde; the content of 3 ingredients of pyrogallic acid, methyl gallate and protocatechuic aldehyde in the garden burnet root charcoal is higher than that in the garden burnet root, which is probably an inherent mechanism for enhancing the antibacterial effect after the garden burnet root is processed.
2. Microscopic observation of administration of trichophyton rubrum by charred sanguisorba officinalis
The 1 × MIC and 0.5 × MIC wells of the 96-well plate completed with the test were photographed 10 times with an eyepiece and 40 times with an objective lens. The results are shown in FIG. 4, where A is a control well for normal growth, and hyphae are clearly separated, and after administration of Garden burnet root charcoal (0.5 × MIC), as shown in B, hyphae separation begins to become fuzzy, with a tendency to fuse, and the drug influences the hyphae growth. Charred sanguisorba officinalis was administered at MIC (panel C), hyphae were hardly separated and growth was significantly inhibited.
Example 5 Observation of therapeutic Effect of Garden Burnet root charcoal on treating tinea pedis
According to the revised edition of 'Chinese guidelines for diagnosing and treating tinea corporis and tinea cruris' 2018, the aim of treating tinea corporis and tinea cruris is to eliminate pathogenic bacteria, quickly relieve symptoms, eliminate skin lesions and prevent relapse. The evaluation criteria of the curative effect are that the erythema, pimple and scale are completely removed, the fungus microscopic examination and/or culture is negative, and the recovery can be considered. After the skin lesion of some patients is removed, temporary pigmentation can be left on the local part.
1. Preparation of sanguisorba officinalis charcoal gel
Carbomer 940 gel 1g was sprinkled in 100mL water overnight and triethanolamine adjusted the gel pH to 5. Taking 0.5g of dried powder of 75% ethanol extract of sanguisorba officinalis charcoal (the preparation method is shown in item 2 in example 1), redissolving the dried powder by using 75% ethanol until no precipitate exists, adding the redissolved powder into 100g of prepared gel (carbomer 940), uniformly stirring, carrying out rotary evaporation by using a rotary evaporator until no alcohol smell exists, supplementing the gel to 100g with water, and uniformly mixing to obtain the sanguisorba officinalis charcoal gel with the drug content of 0.5%.
2. General data
52 patients with tinea pedis, 23 men and 29 women, age 18-48 years, mean (26.32 +/-8.13) years and mean course (28.75 +/-21.62) months are selected.
3. Method of treatment
The sanguisorba officinalis charcoal gel is applied to the affected part for external use. The use method comprises the following steps: taking appropriate amount of Garden Burnet root charcoal gel before sleeping at night every day, directly applying on affected part skin, and continuously administering for 4 weeks.
4. Criteria for efficacy assessment
And (3) healing: clinical symptoms and physical symptoms disappear, and the direct microscopic examination result of the fungi is negative;
the effect is shown: the subjective symptoms and the skin damage condition are improved, and the direct microscopic examination result of the fungi is negative;
improvement: the subjective symptom and the skin damage are improved by 30 to 70 percent, and the direct microscopic examination result of the fungi is negative or positive;
and (4) invalidation: the subjective symptoms and the skin damage are not improved or aggravated, and the direct microscopic examination and culture results of the fungi are positive.
The apparent cure rate is (number of cure cases + number of effective cases + number of improvement cases)/total number of cases × 100%.
5. Results of clinical effects
The clinical curative effect results are shown in Table 5, and it can be seen that the cure rate reaches 96.15% after the sanguisorba officinalis charcoal gel is used for treating for 4 weeks, and half of patients are cured.
TABLE 5 clinical curative effect (example) of patients
Figure BDA0002549312910000081

Claims (8)

1. The sanguisorba officinalis charcoal is applied to prevention and treatment of tinea corporis, tinea cruris, tinea manus and tinea pedis.
2. The garden burnet root charcoal is applied to the preparation of medicaments or daily necessities for preventing and treating tinea corporis, tinea cruris, tinea manus and pedis.
3. A medicine or daily necessities capable of preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis is characterized in that: the prescription contains charred radix Sangusorbae.
4. The medicament or daily item according to claim 3, wherein: the radix Sangusorbae charcoal is radix Sangusorbae charcoal powder or extract.
5. The medicament or daily item according to claim 4, wherein: the extraction solvent of the garden burnet root charcoal extract is ethanol water solution.
6. The medicament or daily item according to claim 5, wherein: the extraction solvent of the garden burnet root charcoal extract is a 75% ethanol extract.
7. Application of one or more of gallic acid, pyrogallic acid, gallic acid methyl ester, gallic acid ethyl ester, and protocatechuic aldehyde in preventing and treating tinea corporis, tinea cruris, tinea manus, and tinea pedis.
8. A medicine or daily necessities capable of preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis is characterized in that: the prescription contains one or more of gallic acid, pyrogallic acid, gallic acid methyl ester, gallic acid ethyl ester, and protocatechuic aldehyde.
CN202010570186.XA 2020-06-21 2020-06-21 Application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis Pending CN111514203A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010570186.XA CN111514203A (en) 2020-06-21 2020-06-21 Application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010570186.XA CN111514203A (en) 2020-06-21 2020-06-21 Application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis

Publications (1)

Publication Number Publication Date
CN111514203A true CN111514203A (en) 2020-08-11

Family

ID=71912948

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010570186.XA Pending CN111514203A (en) 2020-06-21 2020-06-21 Application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis

Country Status (1)

Country Link
CN (1) CN111514203A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113288942A (en) * 2021-06-16 2021-08-24 南京中医药大学 Application of garden burnet root charcoal extract in external antipruritic preparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105435012A (en) * 2015-12-19 2016-03-30 覃敢 Tincture used for treating hemorrhoid, and preparation method thereof
CN109674865A (en) * 2019-03-01 2019-04-26 天津中医药大学 A kind of burn and scald medicament and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105435012A (en) * 2015-12-19 2016-03-30 覃敢 Tincture used for treating hemorrhoid, and preparation method thereof
CN109674865A (en) * 2019-03-01 2019-04-26 天津中医药大学 A kind of burn and scald medicament and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
何慧英等: "复方苦参酊抗真菌实验及临床疗效观察", 《浙江中医学院学报》 *
吴晶: "中药抗真菌的活性筛选及作用机制研究", 《中国优秀博硕士学位论文全文数据库(硕士) 医药卫生科技辑》 *
艾尼瓦尔•塔力甫等: "高效液相色谱法测定维药夏塔热片中没食子酸的含量", 《中国民族医药杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113288942A (en) * 2021-06-16 2021-08-24 南京中医药大学 Application of garden burnet root charcoal extract in external antipruritic preparation

Similar Documents

Publication Publication Date Title
CN100569273C (en) A kind of external Chinese medicine that is used for the treatment of skin tumour, tinea, wart, herpes
CN101862351A (en) Application of active parts of gallnut in preparing anti-ulcerative colitis medicine
CN111870568B (en) Anti-allergy itching-relieving plant composition and preparation method and application thereof
CN106511512A (en) Traditional Chinese medicine external-use gel and preparation method and application thereof
US20210008145A1 (en) Edicine composition for treatment of human papillomavirus infection and preparation method thereof
CN102085248B (en) Traditional Chinese medicinal composition for treating cervix diseases, method for preparing same and method for detecting same
CN111514203A (en) Application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis
CN101040957B (en) Medicine for treating skin diseases such as eczema and dermatitis and the method for preparing the same
CN110664858B (en) Artemisia annua extract composition for skin, product and application thereof
CN101181474B (en) Chinese medicine ointment for curing skin diseases as well as producing and detecting method thereof
CN108324749B (en) Traditional Chinese medicine composition for treating acne and preparation method and application thereof
CN105326954B (en) A kind of Chinese medicine composition and preparation method thereof for treating blear-eye
CN101224245A (en) Quality controlling method of Chinese traditional medicine for treating gynecology inflammation
CN103897010A (en) Composition for treating psoriasis and preparation method thereof
CN102145072A (en) Traditional Chinese medicine composition for treating infantile eczema and dermatitis skin diseases
CN105770099A (en) Externally applied traditional Chinese medicine for treating tinea corporis and cruris and tinea manus and pedis
CN112294929A (en) Gynecological traditional Chinese medicine salt lotion and preparation method and application thereof
CN105983021A (en) External-use medicinal composition as well as preparation method and applications thereof
Akila Formulation and evaluation of wound healing effect of aqueous herbal cream containing various extracts of Passiflora foetida Linn., leaves
CN109470788A (en) A kind of method of quality control of FUKE QIANJIN PIAN
CN109364148A (en) A kind of FUKE QIANJIN PIAN and preparation method thereof
CN103920010A (en) Medicinal composition with bleeding-stopping, pain-relieving and inflammation-diminishing effects, preparation method and application thereof
CN104688823B (en) Antipruritic Chinese medicine composition of a kind of anti-inflammation and preparation method thereof
CN103083523B (en) Traditional Chinese medicine composition for treating chronic prostatitis and preparation method of composition
RU2815993C1 (en) Composition of traditional chinese medicine for treating novel coronavirus pneumonia, method for preparation thereof, method for determinination and use thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Gu Wei

Inventor after: Chen Jun

Inventor after: Su Man

Inventor after: Wang Hao

Inventor after: Gu Qi

Inventor after: Liang Ying

Inventor before: Gu Qi

Inventor before: Liang Ying

Inventor before: Chen Jun

Inventor before: Gu Wei

Inventor before: Su Man

Inventor before: Wang Hao

CB03 Change of inventor or designer information